Determining Concentrations –
Building Trust.
Quantification of patient-specific formulations
Concentration Determination
At IUTA, we offer the quantification of cytostatic drugs and monoclonal antibodies in patient-specific formulations. In the list of substances, you will find an overview and further information, including details about our accreditation under DIN EN ISO 17025.
To enhance patient safety, IUTA offers precise concentration analysis of patient-specific compounding.
This service serves as a key component of quality assurance in the pharmaceutical sector and helps pharmacies and manufacturing facilities regularly verify compliance with their high quality standards.
As part of this service, pharmacies and manufacturing facilities have the option to send selected preparations—such as returns, samples from routine production, or preparations made during training—to IUTA. Once there, the samples are analyzed to verify that the specified active ingredient concentrations are reliably maintained.
In addition to analyzing conventional cytostatic drugs, IUTA also offers content and identity testing for monoclonal antibodies. These tests are conducted using accredited analytical methods in accordance with DIN EN ISO 17025.
Through these services, IUTA makes a decisive contribution towards ensuring the long-term safety and efficacy of patient-specific drug preparations and towards strengthening confidence in the pharmaceutical supply chain.